Highlights

  • Vitrafy Life Sciences shares rose 1.45% to AUD 2.80 on 19 June 2026, extending one-year gains to 112.12%.
  • The company opened a non-underwritten Share Purchase Plan targeting approximately AUD 2 million.
  • Eligible shareholders may apply for up to AUD 30,000 worth of new shares at AUD 2.60 per share.
  • The SPP follows Vitrafy’s AUD 30 million institutional placement announced on 12 June 2026.
  • Funds from the Placement and SPP will support Guardion device manufacturing, U.S. operations, sales and marketing, working capital and placement costs.
  • The SPP is scheduled to close at 5:00pm AEST on Friday, 3 July 2026.

Vitrafy Life Sciences Limited (ASX:VFY) shares traded higher during the morning session on 19 June 2026 after the company opened its Share Purchase Plan for eligible shareholders. The stock rose 1.45% to AUD 2.80, adding AUD 0.040 on the day, while remaining up 112.12% over the past year.

The share price movement followed the company’s announcement that eligible shareholders in Australia and New Zealand can now participate in a non-underwritten Share Purchase Plan, under which Vitrafy is seeking to raise approximately AUD 2 million. The SPP comes after the company completed an institutional placement announced on 12 June 2026, which raised AUD 30 million.

The update appears favourable from a funding and shareholder participation perspective, as the company is extending the same AUD 2.60 issue price paid by institutional investors to eligible shareholders. However, as with any equity raising, investors may also consider the potential dilution from new shares being issued.

About Vitrafy Life Sciences

Vitrafy Life Sciences is an Australian life sciences technology company headquartered in Melbourne and listed on the Australian Securities Exchange under the ticker VFY. The company has developed a proprietary cryopreservation ecosystem designed to support the handling, storage and movement of sensitive biological materials.

Its technology platform includes the Guardion cryopreservation freezing unit and Lifechain, a cloud-based software platform. Together, these products are intended to provide an integrated cryopreservation solution across collection, storage and delivery processes.

Vitrafy’s ecosystem is aimed at helping industries preserve biomaterial quality and maintain the integrity of valuable biological samples. The company’s latest capital raising is connected to its plan to fund Guardion device manufacturing, accelerate U.S. operations and support commercial activities.

SPP Opens for Eligible Shareholders

Vitrafy announced that the SPP opened on Friday, 19 June 2026, and is scheduled to close at 5:00pm AEST on Friday, 3 July 2026.

The offer is available to shareholders who were registered holders of Vitrafy shares at 7:00pm AEST on Thursday, 11 June 2026, and whose registered address is in Australia or New Zealand. Participation is voluntary, meaning eligible shareholders are not required to take part if they do not wish to apply for additional shares.

Under the offer, eligible shareholders can apply for up to AUD 30,000 worth of new fully paid ordinary shares. The offer is non-renounceable, which means the right to participate cannot be transferred to another party.

Vitrafy has also stated that the SPP is not underwritten and is intended to raise a maximum of approximately AUD 2 million. The company may close the offer early or scale back applications at its discretion.

Issue Price Set at AUD 2.60 Per Share

The SPP shares are being offered at AUD 2.60 per new share, which is the same price paid by institutional investors under the AUD 30 million placement announced earlier in June.

This issue price is below the morning session trading price of AUD 2.80 on 19 June 2026. Based on those figures, the SPP price represents a difference of AUD 0.20 per share compared with the market price stated by the user. However, the company also noted in the booklet that the market price of Vitrafy shares may move between the date of the offer and the issue date.

Eligible shareholders may apply for fixed parcels of AUD 2,500, AUD 5,000, AUD 10,000, AUD 15,000, AUD 20,000 or AUD 30,000. At the AUD 2.60 issue price, those parcels correspond to 962 shares, 1,924 shares, 3,847 shares, 5,770 shares, 7,693 shares and 11,539 shares, respectively.

The company has cautioned that applications may be scaled back if demand exceeds the targeted amount. If a scale-back occurs, shareholders may receive fewer shares than applied for, with excess application money refunded without interest.

Funding Follows AUD 30 Million Placement

The SPP follows Vitrafy’s institutional placement, which raised AUD 30 million at the same issue price of AUD 2.60 per share.

The company said proceeds from the placement and the SPP will be used to support several business priorities. These include manufacturing Guardion devices to meet anticipated demand, accelerating U.S. operations, funding sales and marketing activities, providing working capital and covering costs associated with the placement.

This funding structure gives eligible retail shareholders an opportunity to participate at the same price as institutional investors, while also adding further capital to support Vitrafy’s operating and commercial plans.

For investors, the key point is that the SPP is not being presented as a standalone capital raising. Instead, it forms part of a broader funding package that began with the AUD 30 million institutional placement.

Key Dates Investors Should Watch

Vitrafy has provided a timetable for the SPP, although the company has also stated that dates may change, except for the record date.

The SPP opened on Friday, 19 June 2026. The closing date is expected to be Friday, 3 July 2026, at 5:00pm AEST. The company expects to announce the SPP results on Wednesday, 8 July 2026.

New shares under the SPP are expected to be issued on Thursday, 9 July 2026, with trading of those shares expected to commence on Friday, 10 July 2026. Holding statements are also expected to be dispatched on Friday, 10 July 2026.

These dates are important for eligible shareholders considering participation, particularly as payment must be received before the closing deadline. Vitrafy has noted that financial institutions may apply earlier cut-off times for electronic payments.

Application Process and Eligibility

Eligible shareholders can apply through BPAY if they hold an account with an Australian financial institution that supports BPAY transactions. Eligible shareholders in New Zealand who are unable to pay via BPAY may apply through Electronic Funds Transfer.

The company has stated that cheque, bank draft, money order and cash payments will not be accepted.

Shareholders in the United States are not eligible to participate in the SPP. Similarly, shareholders holding shares on behalf of persons in the United States, or acting for the account or benefit of persons in the United States, are not permitted to participate for those persons.

Once issued, the SPP shares will rank equally with existing Vitrafy shares. This means they will carry the same rights and entitlements as current fully paid ordinary shares on issue.

Why the Update Matters for Investors

The market’s positive response appears to reflect the broader funding context rather than the SPP alone. Vitrafy has already secured AUD 30 million through the institutional placement, and the SPP now gives eligible shareholders an opportunity to participate at the same AUD 2.60 issue price.

The update also provides more detail on how the company intends to deploy the new capital. Manufacturing Guardion devices, accelerating U.S. operations, expanding sales and marketing, and supporting working capital are all stated priorities under the funding plan.

At the same time, investors may consider the effect of new share issuance. While the SPP offers eligible shareholders access to new shares without brokerage or transaction costs, the issue of additional equity can increase the number of shares on issue.

The company’s share price remains well above its level from a year ago, with VFY up 112.12% over the past year based on the price information provided. This longer-term movement suggests the company has attracted increased market attention, while the latest update adds a fresh funding milestone to the investment narrative.

What Comes Next for Vitrafy

The immediate focus will be on the level of shareholder participation in the SPP and whether Vitrafy receives applications above the targeted AUD 2 million amount.

If demand exceeds the target, the company may scale back applications. If the SPP proceeds according to the current timetable, the results are expected on 8 July 2026, with new shares expected to begin trading on 10 July 2026.

Beyond the SPP, investors will likely watch how Vitrafy applies the funds raised from the placement and SPP. The company has specifically identified Guardion device manufacturing, U.S. operations, sales and marketing activity, working capital and placement costs as the planned use of proceeds.

For now, the latest announcement keeps Vitrafy in focus, with the company extending its capital raising to eligible shareholders following a sizeable institutional placement.